SafeHeal named Karl Blohm as CEO. Blohm is a senior executive with more than 25 years of experience managing international business operations, combining capital equipment and medical devices. He was most recently vice president - international at GI Dynamics, and previously served in various roles at Accuray, EndoGastric Solutions, and Siemens.
Mazor Robotics appointed Ron Tavlin as vice president of business development. Tavlin has more than 25 years of experience with public and private companies. Prior to joining Mazor, he was a consultant for the Medtronic ventures and corporate development teams. Previously, he was chief operating officer of BlueWind Medical, and a co-founder and managing partner of Omega Capital.
In vitro diagnostics company Atlas Genetics named Jeffrey R. Luber as CEO. Luber brings broad experience in the life sciences industry. Most recently, he led the sale of Good Start Genetics to Invitae and entered into strategic partnerships with Roche Diagnostics and Amazon.